New chapter unfolding in the fight against dengue with an unwritten ending

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 108, Issue 10, 2014, Pages 597-598

  Thiry, Georges ^a,b   Hombacha, Joachim ^a,c   Constenlaa, Dagna ^a,d   Carvalhoa, Ana ^a,e   Durbina, Anna ^a,d  

^a Seoul National University   (South Korea)

^b International Vaccine Institute   (South Korea)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d IVAC   (United States)

^e SABIN VACCINE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE; LIVE VACCINE;

DENGUE; DENGUE VIRUS 2; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HEALTH PROGRAM; HUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); SEROTYPE; VACCINATION;

CLINICAL TRIALS, PHASE III AS TOPIC; DENGUE; DENGUE VACCINES; HUMANS; VACCINES, ATTENUATED;

EID: 84929505759     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/tru149     Document Type: Editorial

References (6)

1. WHO. Better environmental management for control of dengue. Geneva: World Health Organization; 2014. http://www.who.int/heli/risks/vectors/denguecontrol/en/[accessed11 August 2014].
2. WHO. Fact Sheet No 117. January 2012. Geneva: World Health Organization; 2012. http://www.who.int/mediacentre/factsheets/fs117/en/[accessed11 August 2014].
3. Shepard DS, Coudeville L, Halasa YA et al. Economic impact of dengue illness in the Americas. Am J Trop Med Hyg 2011;84:200-7.
4. WHO. Q&A on the dengue phase 3 study. Geneva: World Health Organization; 2014. http://www.who.int/immunization/research/development/dengue_vaccines/en/[accessed11 August 2014].
5. Capeding MR, Tran NH, Hadinegoro SR et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet 2014;pii:S0140-6736(14)61060-6.
6. Sabchareon A, Wallace D, Sirivichayakul C et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet 2012;380:1559-67.